147 related articles for article (PubMed ID: 29546349)
1. Cancer glycan epitopes: biosynthesis, structure and function.
Pearce OMT
Glycobiology; 2018 Sep; 28(9):670-696. PubMed ID: 29546349
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques.
Haga Y; Ueda K
Glycoconj J; 2022 Apr; 39(2):303-313. PubMed ID: 35156159
[TBL] [Abstract][Full Text] [Related]
3. Aberrant glycosylation as biomarker for cancer: focus on CD43.
Tuccillo FM; de Laurentiis A; Palmieri C; Fiume G; Bonelli P; Borrelli A; Tassone P; Scala I; Buonaguro FM; Quinto I; Scala G
Biomed Res Int; 2014; 2014():742831. PubMed ID: 24689054
[TBL] [Abstract][Full Text] [Related]
4. Identification of the binding roles of terminal and internal glycan epitopes using enzymatically synthesized N-glycans containing tandem epitopes.
Wu Z; Liu Y; Ma C; Li L; Bai J; Byrd-Leotis L; Lasanajak Y; Guo Y; Wen L; Zhu H; Song J; Li Y; Steinhauer DA; Smith DF; Zhao B; Chen X; Guan W; Wang PG
Org Biomol Chem; 2016 Nov; 14(47):11106-11116. PubMed ID: 27752690
[TBL] [Abstract][Full Text] [Related]
5. Cadherins Glycans in Cancer: Sweet Players in a Bitter Process.
Carvalho S; Reis CA; Pinho SS
Trends Cancer; 2016 Sep; 2(9):519-531. PubMed ID: 28741480
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation Changes in Serum Proteins Identify Patients with Pancreatic Cancer.
Drabik A; Bodzon-Kulakowska A; Suder P; Silberring J; Kulig J; Sierzega M
J Proteome Res; 2017 Apr; 16(4):1436-1444. PubMed ID: 28244758
[TBL] [Abstract][Full Text] [Related]
7. Lectins as pattern recognition molecules: the effects of epitope density in innate immunity.
Dam TK; Brewer CF
Glycobiology; 2010 Mar; 20(3):270-9. PubMed ID: 19939826
[TBL] [Abstract][Full Text] [Related]
8. Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics.
Taniguchi N; Korekane H
BMB Rep; 2011 Dec; 44(12):772-81. PubMed ID: 22189679
[TBL] [Abstract][Full Text] [Related]
9. Relevance of glyco-biomakers and glycan profiles in cancer stem cells.
Pujari R; Dubey SK
Glycobiology; 2024 Apr; 34(6):. PubMed ID: 36864577
[TBL] [Abstract][Full Text] [Related]
10. N-glycan and Alzheimer's disease.
Kizuka Y; Kitazume S; Taniguchi N
Biochim Biophys Acta Gen Subj; 2017 Oct; 1861(10):2447-2454. PubMed ID: 28465241
[TBL] [Abstract][Full Text] [Related]
11. Functional impact of tumor-specific N-linked glycan changes in breast and ovarian cancers.
Guo H; Abbott KL
Adv Cancer Res; 2015; 126():281-303. PubMed ID: 25727151
[TBL] [Abstract][Full Text] [Related]
12. Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.
Chugh S; Gnanapragassam VS; Jain M; Rachagani S; Ponnusamy MP; Batra SK
Biochim Biophys Acta; 2015 Dec; 1856(2):211-25. PubMed ID: 26318196
[TBL] [Abstract][Full Text] [Related]
13. The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications.
de Freitas Junior JC; Morgado-Díaz JA
Oncotarget; 2016 Apr; 7(15):19395-413. PubMed ID: 26539643
[TBL] [Abstract][Full Text] [Related]
14. Omics-based Identification of Glycan Structures as Biomarkers for a Variety of Diseases.
Akiyoshi S; Iwata M; Berenger F; Yamanishi Y
Mol Inform; 2020 Jan; 39(1-2):e1900112. PubMed ID: 31622036
[TBL] [Abstract][Full Text] [Related]
15. A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer.
Cornelissen LA; Van Vliet SJ
Biomolecules; 2016 May; 6(2):. PubMed ID: 27153100
[TBL] [Abstract][Full Text] [Related]
16. Molecular recognition of complex-type biantennary N-glycans by protein receptors: a three-dimensional view on epitope selection by NMR.
Ardá A; Blasco P; Varón Silva D; Schubert V; André S; Bruix M; Cañada FJ; Gabius HJ; Unverzagt C; Jiménez-Barbero J
J Am Chem Soc; 2013 Feb; 135(7):2667-75. PubMed ID: 23360551
[TBL] [Abstract][Full Text] [Related]
17. On the trail of the glycan codes stored in cancer-related cell adhesion proteins.
Hoja-Łukowicz D; Przybyło M; Duda M; Pocheć E; Bubka M
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3237-3257. PubMed ID: 27565356
[TBL] [Abstract][Full Text] [Related]
18. Pros and cons of using aberrant glycosylation as companion biomarkers for therapeutics in cancer.
Kang JG; Ko JH; Kim YS
BMB Rep; 2011 Dec; 44(12):765-71. PubMed ID: 22189678
[TBL] [Abstract][Full Text] [Related]
19. Glycans in cancer and inflammation--potential for therapeutics and diagnostics.
Dube DH; Bertozzi CR
Nat Rev Drug Discov; 2005 Jun; 4(6):477-88. PubMed ID: 15931257
[TBL] [Abstract][Full Text] [Related]
20. Glycan and lectin microarrays for glycomics and medicinal applications.
Katrlík J; Svitel J; Gemeiner P; Kozár T; Tkac J
Med Res Rev; 2010 Mar; 30(2):394-418. PubMed ID: 20099267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
